Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer Inc.

http://www.pfizer.com

Latest From Pfizer Inc.

Pfizer's Elrexfio Shows Long-Term OS, But Convenience Counts Too

The drug maker presented data from the pivotal Phase II trial at EHA showing median OS of more than two years for Elrexfio.

ImmunoOncology Clinical Trials

COVID Vaccines: US FDA Changes Course, Wants New Formulas To Target KP.2 Subvariant ‘If Feasible’

Revised recommendation is based on most recent data on circulating strains in US, where KP.3 is now dominant. Novavax sticks with plans targeting the JN.1 ‘parent strain.’

Coronavirus COVID-19 Vaccines

Pfizer Calls For Sustainable Approach To Ensure Viability Of Biosimilars Market

Global biosimilars player Pfizer is calling for a more sustainable approach to the market to ensure its long-term viability. In the second part of an exclusive interview, Barry Chester, the firm’s global commercial lead for supportive care oncology, tells Generics Bulletin where the company sees room for improvement.

Biosimilars Strategy

US R&D Setbacks For Multiple Japanese Firms

Several Japanese firms are facing R&D challenges and setbacks in the US, in the form of missed Phase III endpoints, trial recruitment difficulties and a Complete Response Letter.

Research & Development Clinical Trials
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Agouron Pharmaceuticals
    • Alpharma Pharmaceuticals LLC
    • American Home Products
    • Amplyx Pharmaceuticals, Inc.
    • Anacor Pharmaceuticals, Inc.
    • Array BioPharma, Inc. (ARRY)
    • Arixa Pharmaceuticals, Inc. Bamboo Therapeutics, Inc.
    • Bioren, Inc,
    • Coley Pharmaceutical Group, Inc.
    • CovX Pharmaceuticals, Inc
    • C.P. Pharmaceuticals International C.V.
    • Encysive Pharmaceuticals
    • Excaliard
    • FoldRx Pharmaceuticals, Inc.
    • Ferrosan Consumer Health
    • GD Searle
    • Hisun-Pfizer Pharmaceuticals Co., Ltd.
    • Hospira, Inc.
    • Icagen, Inc.
    • Idun Pharmaceuticals, Inc.
    • InnoPharma
    • Javelin Pharmaceuticals, Inc.
    • King Pharmaceuticals, Inc.
    • Lederle Laboratories
    • Mayne Pharma Limited
    • Meridica Limited
    • Neusentis
    • Parke-Davis
    • Pharmacia
    • Pharmacia and Upjohn Co.
    • PHT Pharma S.r.l.
    • Powdermed
    • Redvax GmbH
    • ReViral Ltd.
    • Serenex
    • Strato Medical Corp.
    • SUGEN
    • Texas Biothechnology Corporation
    • Thiakis Limited
    • Vicuron Pharmaceuticals
    • ViiV Healthcare
    • Warner-Lambert
    • Wyeth
    • Wyeth-Ayerst Laboratories, Inc.
    • Treerly Health Co., Ltd.
    • Meridian Medical Technologies Inc.
    • Montreal, Inc.
    • Medivation, Inc.
    • Sugen LLC
    • Therachon Holding AG.
    • Jones Pharma Inc.
    • Trillium Therapeutics Inc.
UsernamePublicRestriction

Register